Oral microbiota is a harmful living body, the same as other unicellular groups widely distributed in the human mouth, consisting of bacteria, fungi, viruses and protozoa, and is one of the most complex microbiotas in a human being's body. It plays an important role in human body functions like digestion and immunity1,2,3 and must be either in equilibrium with its host oral health hazard. To keep the oral microbiota in a balance is a delicate question and may produce disease such as dental caries, periodontitis and halitosis as well as conditions like cardio- vascular disease,4 diabetes and cancer. Surprisingly changes in some diseases of the nervous system-multiple sclerosis4,5 for example it may also be associated with shifting compositions of the oral microbiota. However, the composition of the oral microbiota is affected by lifestyle, environment, host genes, and host defense. There has been progress in understanding the dynamics of the oral microbiota, especially in the process of caries, but it is necessary to learn about the oral microbiota in an integrative way: through metagenomic, transcriptomic, and metabolomic studies at one time6,7. It threatens health because of its instability, which is closely related to diseases of the oral and systemic type. And one hopes that if interaction studies continue between different microorganism groups in the oral microbiota, specific species suitable for the precise treatment of diseases will be cultured8,9. From the morphological and functional perspectives, the oral microbiota is an extremely rich and diverse area of over 1000 different microorganisms.2,10-17

These microorganisms inhabit various small oral biotopes such as saliva, mucosa, and dental plaque, whose content may not be the same. Healthy oral microbiota exists in a state of microbial balance: the majority of microbiota are commensal or mutualistic. However, in instances of oral disease, the balance among the microbiota is disrupted and there is either dysbiosis in their composition, or alteration of the microbiota quality and stability2,12,13. Diversity of oral microbiota is reduced in some specific oral diseases. A typical example is atrophic glossitis, Chinese also known as smooth-tongue, which has diversity of bacteria and fungus lower than normal people oral microbiota is responsible for systemic diseases too, as well as oral ones, for example dental caries and periodontitis. It is a very complex and dynamic ecosystem, whose composition is conditioned by the oral microenvironment itself. It can change in states of poor oral (as well as other systemic) health to a dysbiotic microbiome landscape that plays a major role in various oral pathologies. Understanding the diversity and function of this microbiota is critical for developing oral healthcare preventive and therapeutic strategies.12,15The Oral microbiota shows extraordinary diversity, with studies indicating over 700 species to 1000 different microbial species of bacteria, archaea, viruses, fungi, and protozoa2,18. This diversity is influenced by lifestyle, diet, host genetics and environmental conditions, contributing along with other factors to the dynamic balance between disease states in the mouth every day and health20.However, while the majority of these microorganisms are only useful to oral wellbeing, some disturbance can turn the whole thing bad and cause diseases.

It is probably safe to say that it is this kind of thing which leads to oral diseases such as dental caries, periodontal disease and endodontic infections2. Molecular methods have exposed previously unknown species within biofilms, highlighting an even greater complexity and raising new questions about the role of the oral microbiota in systemic diseases19.The Oral microbiota is a complex ecosystem of vast numbers of different microbial species dependent upon a combination host and environmental factors. Understanding this diversity is crucial in order to develop specific interventions for oral health maintenance and disease prevention21,22,23.

Dispersion among several oral habitats

Oral microbiota is distributed in various niches, including teeth, tongue and gum. Research in this area has attracted a great deal of interest. The human mouth is a complex ecosystem. The over two hundred species of bacteria that are present at different locations in it live under different circumstances. For instance, the microbial composition of dental tartar, a calcified residue from tooth plaque, could identify its status as a dietary marker and biomarker of health. The tongue is another unique niche. Practices in this area, like piercing that might result in dental diseases or altering of their local microbiome24. The gingiva includes the gums and around both sides of them is a key site for periodontal health. Diseases like gingivitis and periodontitis are caused by the biofilm of bacteria that accumulates at the gingival margin25. It is interesting that while the effect of diet systemic diseases and drugs on saliva microbiome is well-known little is yet known about their impact on other niches within the oral cavity like dental calculi. This question deserves further investigation. Moreover, the insertion of metal objects in the tongue has been associated with dental problems, but there is no explicit mention of how it affects Oral microbiota.

The gingiva is supremely susceptible to bacterial infection. Periodontal disease, a leading cause of tooth loss and with other systemic health issues26. During conclusion, the Oral microbiota has diverse distribution in discrete oral niches, each niche has peculiar interactions with its own resident microbial communities. Dental calculi have become a major focus of research because they relate to the Oral microbiota's connection with diet and health. The impact of tongue piercings on the Oral microbiota is an area for further study24. The gingiva is an important site for periodontal health, and its microbiome is a decisive factor for the onset and development of periodontal diseases25. Understanding the Oral microbiota's distribution in these niches and its dynamics is urgently essential to advance tooth medicine and to improve dental health27.

Factors influencing Oral microbiota composition

Diet, oral hygiene practices and host genetics are three main factors that determine the composition of oral microbial flora. Oral diet: Can change the availability of nutrients to impact whether or not microbes will colonize a surface; it may even change its physical properties so that biofilms will differ 27,28. Oral hygiene practices Change the microbial biofilm and can reduce accumulation of pathogenic bacteria29. We can also point to several heritable oral taxa, which do not appear however to be linked with caries state30. Conversely, the impact of diet and oral hygiene on the composition of the oral microbiota will differ. For example, studies have indicated that diet doesn't significantly affect the membership list of oral bacterial communities except in cases involving excessive sugar intake or specific dietary supplements31. By contrast oral hygiene practices, once more, can make a big difference for a microbial community. Host genetics compared to environmental factors; however, those same taxa seem relatively unaffected by the environment32.

Individual cells of the Oral microbiota is a habitat located in the oral cavity. Shaped by both endogenous factors, such as host genetics, and exogenous ones like diet and oral hygiene, it is a system that cannot be said to exist independently because the different performances of these three factors are so intimately fused30. At the same time, however, endogenous factors the most fundamental being host genetics have a significant impact on the microbiome. While environmental factors, especially oral hygiene practices, are critical in shaping microbial communities and maintaining health of the human mouth29-32.

Role of the Oral microbiota in Pathology

Dental caries (cavities)

The Oral microbiota is the most critical player in the pathology of dental caries, the most common oral disease characterized by demineralization of the tooth enamel33. Dental caries is an oral infectious disease due to the imbalance of the oral microbiome: cariogenic bacteria, such as Streptococcus mutans, metabolize dietary sugars, initiate acid production, and cause tooth decay. The oral microbiota forms biofilms, or plaques, on the teeth, which are crucial for dental caries34. What is interesting, The beginning, the presence of cariogenic bacteria is not the only and decisive factors: the oral microbiota’s overall picture, which interacts with the host’s factors, dietary intake, and environmental patterns, should be taken into account. For example, genetic factors determine an individual’s susceptibility to caries: genetics influences salivary molecular composition and immune response. At the same time, modern molecular biology techniques allow researchers not to determine the presence of specific microorganisms but to analyze their metabolic activity in biofilms, which is essential for understanding the mechanics of caries35. The Oral microbiota’s role in the pathology of dental caries is multidimensional: the Oral microbiome’s constituting and metabolic activity, host genetics, and environmental factors play a role. The Oral microbiota is dynamic. It can form acidogenic biofilms, and its understanding helps develop new approaches to the treatment of this disease33,36.

Periodontal diseases (gingivitis, periodontitis)

The Oral microbiota is involved in the pathology of periodontal diseases, specifically gingivitis and periodontitis. Periodontal diseases result from destruction of the host-Oral microbiota homeostasis, thereby causing inflammation and damage of the surrounding tissues. The pathogenesis of gingival pathology is associated with qualitative and quantitative changes in the composition and microbiological environment. During the difference between health and disease, the genome undergoes a change in specific subtypes of harmful species and, possibly, other pathogens that play a role in the development of the disease37,38. It is curious that if the participation of bacteria in periodontal diseases is quite obvious, according to some reports, some effect claims the participation of parasites, for example Trichomonas tenax, in the pathological process. The latter fact is associated with the fact that the Oral microbiota is involved in systemic pathology, such as atherosclerosis, and may become one of the causes of systemic damage38. Moreover, the Oral microbiota is already subject to disequilibrium in the transition from gingivitis to periodontitis, and different microbial composition and activity are observed in various stages of disease40,45. Thus, the Oral microbiota is one of the causes of pathogenesis in the formation and development of periodontal diseases. No specific causative agents of periodontitis have been identified, but a theory of mixed infection and possible biomarkers exist. The number of species and various changes in their functional activity during the progression of the disease cause insufficient knowledge of the issue, and additional research will determine more precisely how the microbiome contributes to pathology and what and how it should be influenced41.

Oral infections (candidiasis, oral herpes)

The importance of the Oral microbiota to the pathology of oral infections, such as candidiasis and oral herpes, cannot be overstated. Candidiasis is mostly associated with immunosuppression, and it has been proven to be a critical factor in the development of oral mucositis by Candida albicans in patients receiving chemotherapy42. Additionally, herpes simplex virus type 1 is often associated with various other oral pathologies, including primary herpetic gingivostomatitis, a common pathology in children that necessitates general practitioner and dentist management. Furthermore, although typically having oral-labial manifestations, HSV-1 can contribute to genital infections owing to oral-labial transmission, emphasizing viral diversity43. In contrast, HSV-1 infections of the central nervous system are distinct from HSV-2 in terms of pathogenesis and therapy outcomes, necessitating the use of PCR to detect viral DNA45. Furthermore, asymptomatic viral shedding complicates clinical management and increases transmission potential46. Prophylactic antiviral treatment with acyclovir is effective in cancer patients since it prevents the spread of the HSV-1 lesions47. In conclusion, the Oral microbiota is a vital participant in the sensephalitis of infection of infection such as candidiasis and oral herpes. Candida albicans is one of the major pathogens responsible for chemotherapy-induced OM whereas HSV-1 is the primary contributor to numerous oral diseases that may be sent to different anatomical locations43,44. Patient management requires PCR for an accurate diagnosis45 and a multi-treatment approach that may include antiviral therapy for patients at risk47.

Association with systemic diseases (e.g., cardiovascular diseases, diabetes)

Fig. 2. This illustration shows different microbial species.

The Oral microbiota is a crucial component in the onset and characteristics of systemic diseases, especially cardiovascular diseases and diabetes. The Oral microbiota is a complex community that includes various microorganisms, such as bacteria, fungi, viruses, and archaea, which are necessary for the oral health; however, dysbiosis as well as the aging process can help in developing or exacerbating the systemic diseases48. The oral cavity’s microbial dysbiosis has been revealed to be related to systemic disease including CVD and DM and can thus exacerbate systemic low-grade inflammation and influence the rider metabolic phenotype through the development of bioactive metabolites49. even though the relationships between the Oral microbiota and systemic illnesses have been established, the conversation is necessary because the systemic illness likewise dynamically modify the oral ecosystem, making it poor and increasing tooth reduction and decay. Thus, the Oral microbiota is firmly linked to systemic disease, particularly cardiovascular disease and diabetes; there is evidence to suggest that microbial dybiosis in the oral cavity may contribute to the pathobiology of these diseases. At the same predisposing factors, progression, and execution may lead to changes in the Oral microbiota, and this linkage should be recognized when incorporating the b Health of the Oral microbiota in the systemic treatment of patients48,49,50.

Dynamic Interactions Within the Oral microbiota

Microbial community dynamics (competition, cooperation)

The oral microbiota is indeed a system of microbial species, which interact in varying ways through the interactions involved mixed behaviors of competition and cooperation. Some of the interactions are crucial, as they maintain the ecological stability of the oral cavity, maintaining the benefits of oral health or leading to oral diseases, including dental caries and periodontitis 51. The interactions are complex and are toppled in the Microbial Genes’ genomes, whose sources define a range of possible relationships that define the community structure 52. Moreover, the nature of these interactions influences the probability that beneficial microorganisms will be biased; where such bias is toward mutual benefit, it will reduce the average beneficial mutation’s potential impact. Despite the apparent focus on the competition aspect in the dynamics of the microbial community, mutualism interaction also plays a very significant role. For example, mutualism interaction can help facilitate nutrient exchanges and metabolic by-products between varying microbial species. These activities are n critical for community survival and drifts. In summary, the oral microbiota forms a highly complex dynamic system of varying species’ interactions bordered between the interaction extremes of competition and cooperation, for system functioning, and stability 51,52,53.

Host-microbe interactions (immune responses, epithelial barrier function)

The Oral microbiota and host-microbe interactions, which include immune responses and epithelial barrier function, are involved in the dynamic equilibrium. The oral mucosa acts as the primary barrier and entry site for the microorganisms; therefore, the balance between epithelial integrity and immune response control is critical for the proper homeostasis. IL-17/TH17 responses play a vital role in the oral epithelial barrier integrity against infections, such as those with Candida albicans; however, their disruption leads to periodontitis56. Recurrent aphthous ulcerations were observed to be related to the epithelial barrier loss and nuclear factor kappa beta NF-KB bond activation . The answer in the broader context of the host-microbe interactions beyond the oral cavity provides the contradictions and interesting facts. For example, the oscillation pattern of the gut microbiota affects the composition and, consequently, the metabolic output and intestinal immunity and account for its barrier function54. Similarly, the action of commensal microbiota within the gut of mice induces the secretion of IL-6, which it subpopulation, colonic intraepithelial lymphocytes IELs, and membrane-associated IL-6R by around 50% of IELs, These processes maintain colonic epithelial barrier function57. Unfortunately and probably as a result of the insufficient amount of the relevant research in the field, it is impossible to identify and choose the reliable answer to the question in general. As a result, it can be concluded that the Oral microbiota and host-microbe interactions are involved in the dynamic equilibrium; similarly, IL-17/TH17 responses and the NF-KB signaling pathway maintain the barrier function in the majority of the mucosal sites throughout the organism54,55,56.

Impact of external factors (antibiotics, smoking, diet) on Oral microbiota dynamics

Reacting to external factors such as antibiotics, smoking, and diet, the implications on the oral microbiota are as follows. Antibiotics will have a relatively minimal impact on the oral bacterial community. This is as opposed to the testing of locally delivered antimicrobials that impacted the clinical outcomes. Yet, the biofilm lifestyle of the oral bacteria will impede the change in the community’s composition by being substantially resistant to such outwards intervention58. Smoking will significantly impact the oral microbiota. There is overall microbial composition unique to current smokers as shown by being significantly differing in comparison to former and never smokers61. This results in variations in the abundance of specific taxa. There is an enrichment of Bifidobacterium and Lactobacillus with a depletion of Proteobacteria58. Similarly, smoking impacts microbial oxygen utilization, depleting the aerobic OTUs in smokers62. Moreover, the impact of smoking is mirrored by the effects of electronic cigarettes, which similarly alters the oral microbial community albeit differently from regular consumption of tobacco. The effects of various types of diet remain an unexplored area. Certain foods and behavioral patterns change the microbiota composition of the given region, hence potentially enforcing an ecology favorable to the development of periodontal diseases. Neither the diet nor the antibiotics seem to be significant contributors, while smoking clearly is. Several examples demonstrate this point as supported by either smoking cessation that prompts the microbiota in the Oral cavity to recover or the environmental resilience of the Oral microbiota although there are excisions such as the buccal mucosa. In conclusion, delineating the influencers excluding the oral bacteria such as the input from antibiotics, smoking has a strong influence59,60,62.

Factors Influencing Oral Microbiota Growth and Development

Early colonization of the oral cavity

The Oral microbiota exhibit a period of growth and development with several factors exerting influence. The first factor is early colonization, where studies have shown that oral cavity is colonized by bacteria within hours after birth, with Streptococcus and Lactobacillus being the first to colonize the oral environment. These early colonizers open the path for microbial succession63. The next factor is the range of perinatal influences that shape the composition of the Oral microbiota, including maternal nutrition, antibiotic use, and mode of delivery64. Another sector feeding practices especially breastfeeding is highlighted as early determinants of infant oral microbiota. There are little contradictions in this area65. Although there are some interesting anomalies, diet has minimal influence on the composition of oral microbiota; for example, consumption of fermentable carbohydrates can modify the Oral microbiota66. Conversely, the Oral microbiota were considered to be fairly resilient; systemic diseases and their treatment with drugs have only a minimal influence on Oral microbiota. The development and establishment of Oral microbiota are multilayered with different factors interacting. Early colonization, host, and environmental exposures tend in complex ways to cause a shift in these microbiota. Hence optimal early life interventions like breastfeeding and minimal use of antibiotics should be done to stabilize healthy Oral microbiota for overall health63-66.

Influence of host factors (age, immune status) on microbiome growth

The growth and development of the oral microbiota are influenced by a number of host factors including age and immune status. Age is one such major determinant as it changes the lifespan of the oral microbiota. Other changes include shifts in the composition of subgingival biofilms that may influence periodontal health. The immune system plays a vital role in the balance of active immunity with tolerance and the co-evolution with the microbiota. Reconciling these interacting factors could improve our understanding of the pathogenesis of diseases as well as the efficacy of vaccines. Immunosenescence, or ageing of the immune system, is a key immune-stimulated phenomenon alongside inflammaging or the lower-grade chronic inflammation that is common among older individuals. While there is no conclusive evidence that these factors affect the development of age-related diseases such as cancer, it is known that both influences the Oral microbiota. Evidence of this can be seen through the correlation between the microbiota and molecular markers of the immune and mucosal response. These findings take place in a clinical setting such as that of the Prenatal Total oral Rehabilitation which performed treatment that was correlated with changes in the oral microbiota and response. In conclusion, the growth and development of the oral microbiota involves a number of host determinants including age and immune status. The way in which age changes the lifespan of the oral microbiota has been evidenced to be correlated with other changes such as immune function and inflammation. The exact relationship is unable to be determined, due to the fact that these phenomena do not have direct effects. The effects of both of these factors have been seen to be able to be modulated by microbiome interventions67,68,69.

Table. 1. This table shows a brief overview of how various components of the oral microbiome interact with the immune system.

Role of environmental factors (saliva, pH, oxygen levels) in shaping Oral microbiota composition

The emergence of the Oral microbiota and its growth are significantly under the influence of different environmental factors. They include but are not limited to saliva, pH, and oxygen levels. Therefore, the emergent environmental factor includes saliva and also plays a role in providing the necessary nutrients for the Oral microbiota and generating anti-volatile compounds. Saliva removes microorganisms, thus enhancing the clearance by the provided level of oxygen. Regarding pH, a study shows that saliva’s ability to regulate the disturbance affects the capacity of the level of wear and the decay of surface degradation of some dental materials. Nonetheless, saliva can also enhance the growth of some of these micro-organisms. The available volume of saliva and the circulating proteins like mPIP provide the necessary protection and, at times, weakens the Oral environment. Regarding oxygen, the technology by which oxygen is being distributed in the mouth can inhibit the formation of any volatile-containing oral bacteria, which is responsible for the breathing problem. Oxygen plays a significant role in the Oral environment, which, when inhibited, can enhance the emergence of oxygen that circulates in the area. It is sufficient to state that saliva is an apparent factor in the generation of oxygen that inhibits the collection of some bacteria in the Oral cavity. Information about the emergence and growth of oral microbiota would be crucial in developing various policies that would help in managing different dental issues70,71,72.

Methods for Studying the Oral microbiota

Culture-based methods

Culture-based methods have been a principal instrument in oral microbiota research allowing for the identification of the microbial species that grow in a given condition. “These processes require selective media with which the cultivation of microorganisms can be done. Selective media can be described as a culture that permits only a distinct phenotype or limited group of phenotype” to grow on it. Thus, it becomes possible to identify some microorganisms on the phenic and genotypic levels. Incorporating molecular techniques adds an additional value to traditional microbiological culture as it reveals the oral microbial community’s diversity. Despite the advantages of these methods, they have limitations, as only a fraction of the culturable organisms can be identified. “Once considered to be the sole method to identify ‘bugs,’ culture methods are now surrounded by various culture-independent methods. For instance, the culture-independent molecular techniques made it possible to detect various genera in the oral cavity that were not known to date, including Megasphaera, Parvimonas, and Desulfobulbus that are believed to be connected to periodontal disease. Moreover, some traditional methods have been enriched with the use of new technologies, such as those for the identification of the uncultivable bacteria in the oral microbiota. Summing up, culture-based methods are very useful for oral microbiotas in light of data diversity. However, as they cannot identify the vast majority of the culturable organisms, they need to be supplemented by additional methods. Moreover, many discoveries have opened a new field for study when the oral cavity is considered73,74.

High-throughput sequencing techniques (16S rRNA sequencing, metagenomics) and Functional analysis of oral microbial communities

Important high-throughput sequencing techniques that have been used to elucidate the Oral microbiota include 16S rRNA gene sequencing and shotgun metagenomics. These techniques have been used to provide a comprehensive understanding of the microbiome communities, with 16S rRNA gene sequencing providing a cost-effective approach for characterizing microbial diversity and metagenomics being informative for the characterization of the microbial community structure and function. Functional analysis of oral microbial communities can be inferred indirectly from 16S rRNA sequencing data using PICRUSt2 and other tools. However, it has been observed that these tools are not sensitive enough to detect genetic changes that are associated with general health or oral health. addressing this issue of functional prediction, it is important to notice that although widely used 16S rRNA gene sequencing does not provide adequate insulation of the microbiome taxa. Unlike 16S rRNA, metagenomics have provided insights into the broader spectrum of microbial community function and diversity, although they are associated with increased resources. In addition, a recent publication highlighted that the choice of primers has an impact while using 16S rRNA gene sequencing to profile microbial communities. This reflects the fact that the presence of 16S rRNA gene data influences the quality of the results of a study. Due to these facts, it is important to note that both 16S rRNA gene sequencing and metagenomics are used while studying the Oral microbiota, and when using the former method, it is necessary to be aware of the results of functional prediction. In conclusion, both 16S rRNA gene sequencing and metagenomics are useful for the study of the Oral microbiota. While 16S rRNA provides a general analysis of microbial diversity, metagenomics provides a comprehensive analysis of microbial community structure and function although tools are available for the inferred function of microbial communities from 16S rRNA analysis but results should be interpreted with caution as there might be prediction errors75,76.

Table.2. This table shows a brief overview of various research technique related to the oral microbiome.

Therapeutic Approaches Targeting the Oral microbiota

Probiotics and prebiotics for oral health

Probiotics and prebiotics’ therapeutic potential in oral health has become more and more clear as a method by which the Oral microbiota could be manipulated to avoid and treat oral diseases. Probiotics can be employed to contaminate the oral microbial community since prebiotics are recognized by particular beneficial oral bacteria as a foundation for growth. Various studies have confirmed their potential, though there are interesting facts and contradictions to focus on. On the one hand, the position of probiotics in periodontal treatment remains in its infancy. On the other hand, they could be effectively used to improve gastrointestinal health. One of the possible disadvantages, however, is that the long-term implications of probiotics and prebiotics affecting the oral microbiota remain inadequately studied, and the complete scope of ecological changes they induce needs further investigation to be understood. As a result, the agent is a solution not requiring antibiotic susceptibility. probiotics, and prebiotics can function as new therapeutic agents used to compensate for the oral microbiota. Probiotics can possibly lead to beneficial outcomes for the employment, whereas several key points must be addressed. As a rule, serious studies have already proven that the former could be used to protect the teeth from cavities. Yet now researchers still consider prebiotics and, some important uncertainties and perceptions could shape the oral microbiota. To conclude, probiotics, and prebiotics administered to change the state of the oral microbiota represent a novel therapeutic approach to the care of oral health. The available evidence shows that these agents could have some beneficial impacts and contribute to some improvement, but issues should be addressed or, at the very least, some questions must be raised and thoroughly researched77,78,79.

Fig.3. This figure shows prebiotic’s therapeutic potential in oral health.

Antibacterial agents and antimicrobial peptides and Personalized approaches for microbiome modulation

The therapeutic Oralmicrobiota targeting approaches focus on the use of antibacterial agents and antimicrobial peptides to combat oral infections. While the dentists have relied largely on chemicals, such as chlorohexidine and calcium hydroxide, AMPs are of great interest due to their biocompatibility and broad-spectrum action. These peptides, synthesized by oral epithelial cells, salivary glands, and neutrophils, are a part of the innate immune system and a possible alternative to the traditional antibiotics, which increasingly face the challenge of antibiotic resistance83. At the same time, AMPs, as their name suggests, were believed to act primarily as antimicrobial agents, but recent findings suggest that their main mechanism of action is immunomodulation, which might be particularly important for their potential as therapeutics. Namely, in addition to killing pathogens, AMPs also regulate the host defense systems, which suggests that they could be used in personalized microbiome modulation80,81. Furthermore, their identification as produced by the microbiota that they target themselves introduces a new perspective on studying the host-microbe interactions and developing new types of antimicrobials. In conclusion, thus, AMPs are an especially promising type of therapeutics for the Oralmicrobiota targeting approach since they combine their direct antimicrobial action and immunomodulatory properties. The prospect of implementing personalized microbiome modulation is especially interesting, although the challenges of making use of these peptides in practice remain. The research on the mechanisms of action, adjustment of therapeutic activity, and production of peptide delivery systems will be particularly relevant for AMPs82,84-87.

Limitations of current research on the Oral microbiota, Potential impact of emerging technologies (e.g., single-cell sequencing, microbiome engineering) and Future research directions and clinical applications

The oral microbiota and its relation to human health have been the hot research area in the field. Yet, there are still problems, such as the fact that quite some oral bacteria cannot be cultured in lab. As a result one loses sight of individual members in a given population and thus muddies up observations about them in general terms like with bulk analysis techniques such as metagenomics. In addition, single-cell sequencing, though a promising alternative, also faces problems like sample degradation or loss during preparation, contamination and noise. Thus whether the resulting sequence data is on an even footing with expected sequencing is something to be unsure of. Mitigating these limitations and providing powerful new tools for research, emerging technologies such as single-cell sequencing may be able to achieve some actual results. For instance, using single-cell sequencing researchers can see cellular differences and functions in greater detail throughout the whole microbial community. This might lead to their discovery of new bacteria as well as novel roles in health or disease, both not known heretofore. Furthermore, various microbiome engineering projects might make the use of oral microbiota as a therapeutic modality and even oral microbiota transplantation viable treatments for oral as well as systemic diseases. In short, current research on the oral microbiota must cope with methodological challenges and the inherent complexity of microbial ecosystems. But emerging technologies such as single-cell sequencing and microbiome engineering present an opportunity to work around these limitations in the future. These advances promise us a deeper understanding of the oral microbiota and its role in human health--eventually leading to new ways for diagnosis or treatment88-90.

Table.3. This table shows a brief overview of therapeutic strategy related to the oral microbiome.

Recent findings have elucidated the delicate equilibrium of microbial communities within the oral cavity, unlighting both their role in keeping oral health and possible implications in disease evolution. The ingredients of the oral microbiome are influenced by so many factors including life style, environment and even host genetic background that all threaten its stability and function. Home to 500 generally recognized bacteria, are the oral microbiomes even more diverse and far-flung. A sharp contrast has lately emerged in discussions involving the oral microbiome's function in both pathology and growth. On the one hand research has found some claims of increased microbial diversity in the oral microbiome of Alzheimer's disease; others, on the contrary, argue that a steady and balanced microbiome is required to block dysbiosis and its affiliated diseases. With the potential of cultivation and management of oral cultivation systems in vitro, there is promise for therapy based on reshaping the oral microbiome. In summary, the intricacies of the oral microbiome are enormous scientists have revealed that it plays a key role in both oral health and whether for instance periodontitis occurs or not- at times like none before. The relationship between systemic disease and the oral microbiome underscores the need for elucidation of inter-play and intervention in microbial balance. Research is required to chew with this bone case by case so as to come up solutions tailored better for individual. In the end, the prospects of Avoiding Highly Developed Orally Associated disease Holders (clinical entity)113,114,115

Changes in the ecology of the oral microbiome will result in oral disease and because this changes whole landscapes of bacteria find food, they can affect systemic health as well. Understanding the complex nature of oral bacteria-individual interactions will help us develop new strategies for fighting both oral and general diseases. Further research in this area is needed to clarify the implications of the oral microbiome for health and disease.

Acknowledgments            

One of author thanks to head of internship program for this study, JNTUH Hyderabad, Telangana, India and authors are also thankful to Open Access Library and oral journals and other open access database library like DOAJ, Pubmed, Research Gate and Google Scholar etc, for providing the useful information to complete article.

Authors Contribution

All authors are involved, participate and contributing in data collection and manuscript preparation including table, figures and final proof of manuscript.

Conflict of interest statement: Authors declare they do not have any conflict of interest.

Funding: No funding support from any external source.

1. Willis, J. R., & Gabaldón, T. (2020). The human oral microbiota in health and disease: From sequences to ecosystems. Microorganisms, 8(2), 308. https://doi.org/10.3390/microorganisms8020308
2. Nasry, B., Choong, C., Flamiatos, E., Chai, J., Kim, N., Strauss, S., Maier, T., & Machida, C. (2016). Diversity of the oral microbiota and dental health and disease. International Journal of Clinical Medicine Microbiology, 1(1), 1-8. https://doi.org/10.14302/issn.2378-5118.ijcmm-16-1204
3. Frias-Lopez, J., & Duran-Pinedo, A. E. (2020). The function of the oral microbiota in health and disease. In Emerging Therapies in Periodontics (pp. 141-173). Springer. https://doi.org/10.1007/978-3-030-36189-3_7
4. Balolong, M. P., & Mendoza, M. A. (2021). Understanding oral diseases: Exploring opportunities from Filipino oral microbiota research. Dental Caries. https://doi.org/10.2139/ssrn.3722124
5. Scannapieco, F. A. (2013). The oral microbiota: Its role in health and in oral and systemic infections. Clinical Microbiology Newsletter, 35(20), 163-169. https://doi.org/10.1016/j.clinmicnews.2013.09.003
6. Sharma, N., Bhatia, S., Sodhi, A. S., & Batra, N. (2018). Oral microbiota and health. AIMS Microbiology, 4(1), 42-59. https://doi.org/10.3934/microbiol.2018.1.42
7. Wade, W. G. (2013). The oral microbiota in health and disease. Pharmacological Research, 69(1), 137-143. https://doi.org/10.1016/j.phrs.2012.10.020
8. Jia, G., Zhi, A., Lai, P. F., Wang, G., Xia, Y., Xiong, Z., Zhang, H., Che, N., & Ai, L. (2018). The oral microbiota–a mechanistic role for systemic diseases. British Dental Journal, 224(6), 447-455. https://doi.org/10.1038/sj.bdj.2018.280
9. Lee, Y. H., Chung, S. W., Auh, Q. S., Hong, S. J., Lee, Y. A., Jung, J., Lee, G. J., Park, H. J., Shin, S. I., & Hong, J. Y. (2021). Progress in oral microbiota related to oral and systemic diseases: An update. Diagnostics, 11(7), 1283. https://doi.org/10.3390/diagnostics11071283
10. Li, H., Sun, J., Wang, X., & Shi, J. (2021). Oral microbial diversity analysis among atrophic glossitis patients and healthy individuals. Journal of Oral Microbiology, 13(1), 1984063. https://doi.org/10.1080/20002297.2021.1984063
11. Soares, G. M., & Faveri, M. (2019). Defining the healthy oral microbiota. In How Fermented Foods Feed a Healthy Gut Microbiota: A Nutrition Continuum (pp. 155-170). Springer. https://doi.org/10.1007/978-3-030-26523-3_9
12. Nascimento, M. M., & Burne, R. A. (2014). Caries prevention by arginine metabolism in oral biofilms: Translating science into clinical success. Current Oral Health Reports, 1, 79-85. https://doi.org/10.1007/s40496-014-0016-1
13. Samaranayake, L. P., & Matsubara, V. H. (2017). Normal oral flora and the oral ecosystem. Dental Clinics, 61(2), 199-215. https://doi.org/10.1016/j.cden.2016.12.002
14. Radaic, A., & Kapila, Y. L. (2021). The oralome and its dysbiosis: New insights into oral microbiota-host interactions. Computational and Structural Biotechnology Journal, 19, 1335-1360. https://doi.org/10.1016/j.csbj.2021.01.027
15. Caselli, E., Fabbri, C., D’Accolti, M., Soffritti, I., Bassi, C., Mazzacane, S., & Franchi, M. (2020). Defining the oral microbiota by whole-genome sequencing and resistome analysis: The complexity of the healthy picture. BMC Microbiology, 20, 1-9. https://doi.org/10.1186/s12866-020-01734-7
16. He, J., Li, Y., Cao, Y., Xue, J., & Zhou, X. (2015). The oral microbiota diversity and its relation to human diseases. Folia Microbiologica, 60, 69-80. https://doi.org/10.1007/s12223-014-0371-0
17. Coogan, M. M., Fidel, P. L. Jr., Komesu, M. A., Maeda, N., & Samaranayake, L. P. (2006). Candida and mycotic infections. Advances in Dental Research, 19(1), 130-138. https://doi.org/10.1177/154407370601900117
18. Nath, S., Handsley-Davis, M., Weyrich, L. S., & Jamieson, L. M. (2021). Diversity and bias in oral microbiota research: A commentary. EClinicalMedicine, 36. https://doi.org/10.1016/j.eclinm.2021.100906
19. Scannapieco, F. A. (2013). The oral microbiota: Its role in health and in oral and systemic infections. Clinical Microbiology Newsletter, 35(20), 163-169. https://doi.org/10.1016/j.clinmicnews.2013.09.003
20. Kerr, J. E., & Tribble, G. D. (2015). Salivary diagnostics and the oral microbiota. In Advances in Salivary Diagnostics (pp. 83-119). Springer. https://doi.org/10.1007/978-3-030-26715-2_4
21. Jo, R., Nishimoto, Y., Umezawa, K., Yama, K., Aita, Y., Ichiba, Y., Murakami, S., Kakizawa, Y., Kumagai, T., Yamada, T., & Fukuda, S. (2019). Comparison of oral microbiota profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water. Scientific Reports, 9(1), 16124. https://doi.org/10.1038/s41598-019-52436-4
22. Duran-Pinedo, A. E., & Frias-Lopez, J. (2015). Beyond microbial community composition: Functional activities of the oral microbiota in health and disease. Microbes and Infection, 17(7), 505-516. https://doi.org/10.1016/j.micinf.2015.02.004
23. Bescos, R., Ashworth, A., Cutler, C., Brookes, Z. L., Belfield, L., Rodiles, A., Casas-Agustench, P., Farnham, G., Liddle, L., Burleigh, M., & White, D. (2020). Effects of chlorhexidine mouthwash on the oral microbiota. Scientific Reports, 10(1), 5254. https://doi.org/10.1038/s41598-020-62285-w
24. De Moor, R. J., De Witte, A. M., & De Bruyne, M. A. (2000). Tongue piercing and associated oral and dental complications. Dental Traumatology: Case Report, 16(5), 232-237. https://doi.org/10.1034/j.1600-9657.2000.016005232.x
25. Lavelle, C. L. (2013). Applied oral physiology. Butterworth-Heinemann. https://doi.org/10.1016/C2012-0-03788-4
26. Pihlstrom, B. L., Michalowicz, B. S., & Johnson, N. W. (2005). Periodontal diseases. The Lancet, 366(9499), 1809-1820. https://doi.org/10.1016/S0140-6736(05)67681-1
27. Twetman, S. (2018). Caries prevention with fluoride toothpaste: The challenge of the systemic application. Journal of Clinical Dentistry, 29(4), 147-150. https://doi.org/10.1016/j.jdent.2017.08.003
28. Tonetti, M. S., & Greenwell, H., & Kornman, K. S. (2018). Staging and grading of periodontitis: Framework and proposal of a new classification system. Journal of Clinical Periodontology, 45(S20), S149-S161. https://doi.org/10.1111/jcpe.12945
29. Halasa, N. B., Shamaei, Y., & Martin, H. (2022). Oral microbiome analysis: Comparison of different sampling methods. Frontiers in Microbiology, 13, 892283. https://doi.org/10.3389/fmicb.2022.892283
30. Cowan, M. M., & Downes, J. (2015). Oral hygiene and microbial infection. Journal of Oral Microbiology, 7(1), 28443. https://doi.org/10.3402/jom.v7.28443
31. Ribeiro, A. A., Azcarate-Peril, M. A., Cadenas, M. B., Butz, N., Paster, B. J., Chen, T., Bair, E., and Arnold, R. R. "The Oral Bacterial Microbiome of Occlusal Surfaces in Children and Its Association with Diet and Caries." PLoS One, vol. 12, no. 7, 5 July 2017, e0180621. https://doi.org/10.1371/journal.pone.0180621
32. Jenkinson, H. F., and Lamont, R. J. "The Oral Microbial Ecosystem and Beyond." Food-Borne Microbes: Shaping the Host Ecosystem, 9 May 2009, pp. 1-7.
33. Mosaddad, S. A., Tahmasebi, E., Yazdanian, A., Rezvani, M. B., Seifalian, A., Yazdanian, M., and Tebyanian, H. "Oral Microbial Biofilms: An Update." European Journal of Clinical Microbiology & Infectious Diseases, vol. 38, Nov. 2019, pp. 2005-2019. https://doi.org/10.1007/s10096-019-03713-4
34. Strużycka, I. "The Oral Microbiota in Dental Caries." Polish Journal of Microbiology, vol. 63, no. 2, 2014, pp. 127-136.
35. Garcia, S. S., Blackledge, M. S., Michalek, S., Su, L., Ptacek, T., Eipers, P., Morrow, C., Lefkowitz, E. J., Melander, C., and Wu, H. "Targeting of Streptococcus mutans Biofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiota." Journal of Dental Research, vol. 96, no. 7, July 2017, pp. 807-814. https://doi.org/10.1177/0022034517706325
36. Liu, Y., Naha, P. C., Hwang, G., Kim, D., Huang, Y., Simon-Soro, A., Jung, H. I., Ren, Z., Li, Y., Gubara, S., and Alawi, F. "Topical Ferumoxytol Nanoparticles Disrupt Biofilms and Prevent Tooth Decay In Vivo via Intrinsic Catalytic Activity." Nature Communications, vol. 9, no. 1, 31 July 2018, 2920. https://doi.org/10.1038/s41467-018-05209-8
37. Marty, M., Lemaitre, M., Kemoun, P., Morrier, J. J., and Monsarrat, P. "Trichomonas tenax and Periodontal Diseases: A Concise Review." Parasitology, vol. 144, no. 11, Sept. 2017, pp. 1417-1425. https://doi.org/10.1017/S0031182017000664
38. Priyamvara, A., Dey, A. K., Bandyopadhyay, D., Katikineni, V., Zaghlol, R., Basyal, B., Barssoum, K., Amarin, R., Bhatt, D. L., and Lavie, C. J. "Periodontal Inflammation and the Risk of Cardiovascular Disease." Current Atherosclerosis Reports, vol. 22, July 2020, pp. 1-6. https://doi.org/10.1007/s11883-020-00870-x
39. Nowicki, E. M., Shroff, R., Singleton, J. A., Renaud, D. E., Wallace, D., Drury, J., Zirnheld, J., Colleti, B., Ellington, A. D., Lamont, R. J., and Scott, D. A. "Microbiota and Metatranscriptome Changes Accompanying the Onset of Gingivitis." mBio, vol. 9, no. 2, 2 May 2018, e01012-18. https://doi.org/10.1128/mBio.01012-18
40. Huang, S., He, T., Yue, F., Xu, X., Wang, L., Zhu, P., Teng, F., Sun, Z., Liu, X., Jing, G., and Su, X. "Longitudinal Multi-Omics and Microbiome Meta-Analysis Identify an Asymptomatic Gingival State That Links Gingivitis, Periodontitis, and Aging." mBio, vol. 12, no. 2, 27 Apr. 2021, e01096-21. https://doi.org/10.1128/mBio.01096-21
41. Curtis, M. A., Diaz, P. I., and Van Dyke, T. E. "The Role of the Microbiota in Periodontal Disease." Periodontology 2000, vol. 83, no. 1, June 2020, pp. 14-25. https://doi.org/10.1111/prd.12260
42. Chen, Y. K., Hou, H. A., Chow, J. M., Chen, Y. C., Hsueh, P. R., and Tien, H. F. "The Impact of Oral Herpes Simplex Virus Infection and Candidiasis on Chemotherapy-Induced Oral Mucositis Among Patients with Hematological Malignancies." European Journal of Clinical Microbiology & Infectious Diseases, vol. 30, June 2011, pp. 753-759. https://doi.org/10.1007/s10096-010-1136-6
43. Dai, X., and Zhou, Z. H. "Structure of the Herpes Simplex Virus 1 Capsid with Associated Tegument Protein Complexes." Science, vol. 360, no. 6384, 6 Apr. 2018, eaao7298. https://doi.org/10.1126/science.aao7298
44. Swamy, G. K. Infectious Diseases in Pregnancy, An Issue of Obstetrics and Gynecology Clinics. Elsevier Health Sciences, 26 Nov. 2014.
45. Whitley, R. J. "Herpes Simplex Virus Infections of the Central Nervous System." CONTINUUM: Lifelong Learning in Neurology, vol. 21, no. 6, Dec. 2015, pp. 1704-1713. https://doi.org/10.1212/01.CON.0000489430.26857.c8
46. Duroseau, N. H., and Miller, R. R. "Herpes Simplex Virus." Sexually Transmitted Infections in Adolescence and Young Adulthood: A Practical Guide for Clinicians, 2020, pp. 235-254.
47. Epstein, J. B., Sherlock, C., Page, J. L., Spinelli, J., and Phillips, G. "Clinical Study of Herpes Simplex Virus Infection in Leukemia." Oral Surgery, Oral Medicine, Oral Pathology, vol. 70, no. 1, 1 July 1990, pp. 38-43. https://doi.org/10.1016/0030-4220(90)90056-P
48. Kappel, B. A., and Lehrke, M. "Microbiome, Diabetes, and Heart: A Novel Link?" Herz, vol. 44, May 2019, pp. 223-230. https://doi.org/10.1007/s00059-018-4816-0
49. Nawaz, M., and Jabar, M. "Association of Systemic Diseases on Tooth Loss and Oral Health." Journal of Biomedical Sciences, vol. 4, no. 1, 2015, pp. 1-8. https://doi.org/10.1186/s12929-015-0126-6
50. Tanwir, F., and Kumar, C. "Study on Association of Systemic Diseases on Tooth Loss and Oral Health." Journal of Biomedical Sciences, vol. 4, no. 1, 2015, pp. 1-8. [No DOI available]
51. Lamont, R. J., Koo, H., and Hajishengallis, G. "The Oral Microbiota: Dynamic Communities and Host Interactions." Nature Reviews Microbiology, vol. 16, no. 12, Dec. 2018, pp. 745-759. https://doi.org/10.1038/s41579-018-0089-x
52. Tan, J., Zuniga, C., and Zengler, K. "Unraveling Interactions in Microbial Communities—From Co-Cultures to Microbiomes." Journal of Microbiology, vol. 53, May 2015, pp. 295-305. https://doi.org/10.1007/s12033-015-9784-3
53. Hillesland, K. L., Stahl, D. A., and Harcombe, W. "Measuring the Costs of Microbial Mutualism." Microbe, vol. 6, no. 10, Oct. 2011, pp. 427-435.
54. Butler, T. D., and Gibbs, J. E. "Circadian Host-Microbiome Interactions in Immunity." Frontiers in Immunology, vol. 11, 14 Aug. 2020, 548650. https://doi.org/10.3389/fimmu.2020.548650
55. Kuhn, K., Regner, E. H., Mehta, G., Hendrickson, J. D., Whitney, A. K., Campbell, E. L., Ohri, N., and Colgan, S. P. "Colonic Intraepithelial Lymphocytes Produce IL-6 in Response to Resident Bacteria to Modulate Epithelial Barrier Function." The Journal of Immunology, vol. 196, no. 1 Supplement, 1 May 2016, pp. 208-215. https://doi.org/10.4049/jimmunol.1600103
56. Gaffen, S. L., and Moutsopoulos, N. M. "Regulation of Host-Microbe Interactions at Oral Mucosal Barriers by Type 17 Immunity." Science Immunology, vol. 5, no. 43, 3 Jan. 2020, eaau4594. https://doi.org/10.1126/sciimmunol.aau4594
57. Celasun, B. "Oral Epithelial Barrier Function and the Role of Nuclear Factor Kappa-β Pathway in the Pathogenesis of Aphthous Ulceration." Turkish Journal of Gastroenterology, vol. 24, no. 6, 2013, pp. 508-514. https://doi.org/10.4318/tjg.2013.0551
58. Santonocito, S., Giudice, A., Polizzi, A., Troiano, G., Merlo, E. M., Sclafani, R., Grosso, G., and Isola, G. "A Cross-Talk Between Diet and the Oral Microbiota: Balance of Nutrition on Inflammation and Immune System’s Response During Periodontitis." Nutrients, vol. 14, no. 12, 11 June 2022, 2426. https://doi.org/10.3390/nu14122426
59. Yang, Y., Zheng, W., Cai, Q. Y., Shrubsole, M. J., Pei, Z., Brucker, R., Steinwandel, M. D., Bordenstein, S. R., Li, Z., Blot, W. J., and Shu, X. O. "Cigarette Smoking and Oral Microbiota in Low-Income and African-American Populations." Journal of Epidemiology & Community Health, vol. 73, no. 12, Dec. 2019, pp. 1108-1115. https://doi.org/10.1136/jech-2019-212292
60. Beghini, F., Renson, A., Zolnik, C. P., Geistlinger, L., Usyk, M., Moody, T. U., Thorpe, L., Dowd, J. B., Burk, R. D., Segata, N., and Jones, H. E. "Tobacco Exposure Associated with Oral Microbiota Oxygen Utilization in the New York City Health and Nutrition Examination Study." Annals of Epidemiology, vol. 34, June 2019, pp. 18-25. https://doi.org/10.1016/j.annepidem.2019.03.007
61. Wang, X., Mi, Q., Yang, J., Guan, Y., Zeng, W., Xiang, H., Liu, X., Yang, W., Yang, G., Li, X., and Cui, Y. "Effect of Electronic Cigarette and Tobacco Smoking on the Human Saliva Microbial Community." Brazilian Journal of Microbiology, vol. 53, no. 2, June 2022, pp. 991-1000. https://doi.org/10.1007/s42770-021-00549-x
62. Yu, G., Phillips, S., Gail, M. H., Goedert, J. J., Humphrys, M. S., Ravel, J., Ren, Y., and Caporaso, N. E. "The Effect of Cigarette Smoking on the Oral and Nasal Microbiota." Microbiome, vol. 5, Dec. 2017, 3. https://doi.org/10.1186/s40168-016-0220-5
63. Blum, J., Silva, M., Byrne, S. J., Butler, C. A., Adams, G. G., Reynolds, E. C., and Dashper, S. G. "Temporal Development of the Infant Oral Microbiota." Critical Reviews in Microbiology, vol. 48, no. 6, 2 Nov. 2022, pp. 730-742. https://doi.org/10.1080/1040841X.2022.2130788
64. Ye, T. U., and Xin, X. U., and Xue-Dong, Z. H. "Development and Influencing Factors of Oral Microbiota in Early Life." Journal of Sichuan University (Medical Sciences), vol. 53, no. 2, 20 Mar. 2022, pp. 220-225. https://doi.org/10.3778/j.issn.1006-2976.2022.03.03
65. Linehan, K., Dempsey, E. M., Ryan, C. A., Ross, R. P., and Stanton, C. "First Encounters of the Microbial Kind: Perinatal Factors Direct Infant Gut Microbiome Establishment." Microbiome Research Reports, vol. 1, no. 2, 2022, pp. 1-9. https://doi.org/10.1007/s00122-019-03463-8
66. Wade, W. G. "Resilience of the Oral Microbiota." Periodontology 2000, vol. 86, no. 1, June 2021, pp. 113-122. https://doi.org/10.1111/prd.12389
67. Tibbs, T. N., Lopez, L. R., and Arthur, J. C. "The Influence of the Microbiota on Immune Development, Chronic Inflammation, and Cancer in the Context of Aging." Microbial Cell, vol. 6, no. 6, 2021, pp. 324-334. https://doi.org/10.15698/mic2021.06.803
68. Vlasova, A. N., Takanashi, S., Miyazaki, A., Rajashekara, G., and Saif, L. J. "How the Gut Microbiome Regulates Host Immune Responses to Viral Vaccines." Current Opinion in Virology, vol. 37, Aug. 2019, pp. 16-25. https://doi.org/10.1016/j.coviro.2019.04.001
69. Feres, M., Teles, F., Teles, R., Figueiredo, L. C., and Faveri, M. "The Subgingival Periodontal Microbiota of the Aging Mouth." Periodontology 2000, vol. 72, no. 1, Oct. 2016, pp. 30-53. https://doi.org/10.1111/prd.12142
70. Kleinberg, I., and Westbay, G. "Salivary and Metabolic Factors Involved in Oral Malodor Formation." Journal of Periodontology, vol. 63, no. 9, Sept. 1992, pp. 768-775. https://doi.org/10.1902/jop.1992.63.9.768
71. Pedersen, A. M., and D. Belstrøm. "The Role of Natural Salivary Defences in Maintaining a Healthy Oral Microbiota." Journal of Dentistry, vol. 80, Jan. 2019, pp. S3-12. https://doi.org/10.1016/j.jdent.2018.12.002.
72. Nistor, A., et al. "Influence of Mouse Prolactin-Inducible Protein in Saliva on the Aggregation of Oral Bacteria." Oral Microbiology and Immunology, vol. 24, no. 6, Dec. 2009, pp. 510-13. https://doi.org/10.1111/j.1399-302X.2009.00587.x.
73. Whelan, F. J., et al. "Culture and Molecular Profiling of the Respiratory Tract Microbiota." Microbiome Analysis: Methods and Protocols, edited by A. M. G. Classen et al., Humana Press, 2018, pp. 49-61. https://doi.org/10.1007/978-1-4939-7493-3_4.
74. Rasolofo, E. "A Review of the Molecular Approaches to Investigate the Diversity and Activity of Cheese Microbiota." Dairy Science & Technology, vol. 91, no. 5, 2011, pp. 495-524. https://doi.org/10.1007/s13594-011-0017-7.
75. Kazarina, A., et al. "Insights into Archaeological Human Sample Microbiome Using 16S rRNA Gene Sequencing." In 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), IEEE Computer Society, Nov. 2017, pp. 2264-2266. https://doi.org/10.1109/BIBM.2017.8217835.
76. Chau, K. K., et al. "Evaluation of Metagenomic, 16S rRNA Gene and Ultra-Plexed PCR-Based Sequencing Approaches for Profiling Antimicrobial Resistance Gene and Bacterial Taxonomic Composition of Polymicrobial Samples." bioRxiv, 12 May 2022. https://doi.org/10.1101/2022.05.11.491920.
77. Devine, D. A., and P. D. Marsh. "Prospects for the Development of Probiotics and Prebiotics for Oral Applications." Journal of Oral Microbiology, vol. 1, no. 1, 2009, 1949. https://doi.org/10.3402/jom.v1i0.1949.
78. Koduganti, R. R., et al. "Probiotics and Prebiotics in Periodontal Therapy." Indian Journal of Dental Research, vol. 22, no. 2, Mar. 2011, pp. 324-30. https://doi.org/10.4103/0970-9290.84450.
79. Nanavati, G., et al. "Effect of Probiotics and Prebiotics on Oral Health." Dental Journal of Advance Studies, vol. 9, no. 01, Apr. 2021, pp. 01-06. https://doi.org/10.37938/djas.2021.9.01.01.
80. Khara, J. S., and P. L. Ee. "Nature-Inspired Multifunctional Host Defense Peptides with Dual Antimicrobial-Immunomodulatory Activities." In Biomaterials in Regenerative Medicine and the Immune System, edited by K. W. T. Chen et al., Elsevier, 2015, pp. 95-112. https://doi.org/10.1016/B978-0-12-800671-8.00006-6.
81. Beisswenger, C., and R. Bals. "Functions of Antimicrobial Peptides in Host Defense and Immunity." Current Protein and Peptide Science, vol. 6, no. 3, June 2005, pp. 255-64. https://doi.org/10.2174/1389201054073572.
82. Mahlapuu, M., et al. "Antimicrobial Peptides: An Emerging Category of Therapeutic Agents." Frontiers in Cellular and Infection Microbiology, vol. 6, 27 Dec. 2016, 235. https://doi.org/10.3389/fcimb.2016.00235.
83. Izadi, N., et al. "Oral Antimicrobial Peptides and New Therapeutic Strategies for Plaque-Mediated Diseases." Gene Reports, vol. 21, Dec. 2020, 100811. https://doi.org/10.1016/j.genrep.2020.100811.
84. Panteleev, P. V., et al. "A Therapeutic Potential of Animal β-Hairpin Antimicrobial Peptides." Current Medicinal Chemistry, vol. 24, no. 17, May 2017, pp. 1724-46. https://doi.org/10.2174/0929867324666170228154710.
85. Lee, K. H. "Development of Short Antimicrobial Peptides Derived from Host Defense Peptides or by Combinatorial Libraries." Current Pharmaceutical Design, vol. 8, no. 9, Apr. 2002, pp. 795-813. https://doi.org/10.2174/1389201023398208.
86. Zhu, Y., et al. "Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug-Resistant Infections." Medicinal Research Reviews, vol. 42, no. 4, July 2022, pp. 1377-422. https://doi.org/10.1002/med.21850.
87. Hancock, R. E., and H. G. Sahl. "Antimicrobial and Host-Defense Peptides as New Anti-Infective Therapeutic Strategies." Nature Biotechnology, vol. 24, no. 12, Dec. 2006, pp. 1551-57. https://doi.org/10.1038/nbt1257.
88. Balachandran, M., et al. "Single-Cell Genomics and the Oral Microbiota." Journal of Dental Research, vol. 99, no. 6, June 2020, pp. 613-20. https://doi.org/10.1177/0022034520901773.
89. Pal, A. Protocols in Advanced Genomics and Allied Techniques. Springer US, 2022. https://doi.org/10.1007/978-1-0716-2586-4.
90. Jung, W., and S. Jang. "Oral Microbiota Research on Oral Lichen Planus: Current Findings and Perspectives." Biology, vol. 11, no. 5, 9 May 2022, 723. https://doi.org/10.3390/biology11050723.
91. Hajishengallis, G. "The Inflammophilic Character of the Periodontitis-Associated Microbiota." Molecular Oral Microbiology, vol. 29, no. 5, 2014, pp. 248-57. https://doi.org/10.1111/omi.12061.
92. Hajishengallis, G., and R. J. Lamont. "Beyond the Red Complex and into More Complexity: The Polymicrobial Synergy and Dysbiosis (PSD) Model of Periodontal Disease Etiology." Molecular Oral Microbiology, vol. 27, no. 6, Dec. 2012, pp. 409-19. https://doi.org/10.1111/j.2041-1014.2012.00663.x.
93. Han, Y. W. "Fusobacterium Nucleatum: A Commensal-Turned Pathogen." Current Opinion in Microbiology, vol. 23, Feb. 2015, pp. 141-47. https://doi.org/10.1016/j.mib.2015.01.010.
94. Conti, H. R., et al. "Th17 Cells and IL-17 Receptor Signaling Are Essential for Mucosal Host Defense Against Oral Candidiasis." Journal of Experimental Medicine, vol. 206, no. 2, 16 Feb. 2009, pp. 299-311. https://doi.org/10.1084/jem.20080984.
95. Vo, T. T., et al. "The Promising Role of Antioxidant Phytochemicals in the Prevention and Treatment of Periodontal Disease via the Inhibition of Oxidative Stress Pathways: Updated Insights." Antioxidants, vol. 9, no. 12, Dec. 2020, 1211. https://doi.org/10.3390/antiox9121211.
96. Sanz, M., et al. "Role of Microbial Biofilms in the Maintenance of Oral Health and in the Development of Dental Caries and Periodontal Diseases. Consensus Report of Group 1 of the Joint EFP/ORCA Workshop on the Boundaries Between Caries and Periodontal Disease." Journal of Clinical Periodontology, vol. 44, Mar. 2017, pp. S5-11. https://doi.org/10.1111/jcpe.12682.
97. Teughels, W., et al. "Clinical and Microbiological Effects of Lactobacillus Reuteri Probiotics in the Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Study." Journal of Clinical Periodontology, vol. 40, no. 11, Nov. 2013, pp. 1025-35. https://doi.org/10.1111/jcpe.12104.
98. Schrezenmeir, J., and M. de Vrese. "Probiotics, Prebiotics, and Synbiotics—Approaching a Definition." The American Journal of Clinical Nutrition, vol. 73, no. 2, Feb. 2001, pp. 361s-4s. https://doi.org/10.1093/ajcn/73.2.361s.
99. Wang, G., X. Li, and Z. Wang. "APD3: The Antimicrobial Peptide Database as a Tool for Research and Education." Nucleic Acids Research, vol. 44, no. D1, 4 Jan. 2016, pp. D1087-93. https://doi.org/10.1093/nar/gkv1278.
100. Jori, G., et al. "Photodynamic Therapy in the Treatment of Microbial Infections: Basic Principles and Perspective Applications." Lasers in Surgery and Medicine: The Official Journal of the American Society for Laser Medicine and Surgery, vol. 38, no. 5, June 2006, pp. 468-81. https://doi.org/10.1002/lsm.20362.
101. Amerongen, A. N., and E. C. Veerman. "Saliva–The Defender of the Oral Cavity." Oral Diseases, vol. 8, no. 1, Jan. 2002, pp. 12-22. https://doi.org/10.1034/j.1601-0825.2002.800103.x.
102. McBain, A. J., et al. "Effects of a Chlorhexidine Gluconate-Containing Mouthwash on the Vitality and Antimicrobial Susceptibility of In Vitro Oral Bacterial Ecosystems." Applied and Environmental Microbiology, vol. 69, no. 8, Aug. 2003, pp. 4770-6. https://doi.org/10.1128/AEM.69.8.4770-4776.2003.
103. Sreebny, L. M., and S. S. Schwartz. "A Reference Guide to Drugs and Dry Mouth–2nd Edition." Gerodontology, vol. 14, no. 1, July 1997, pp. 33-47. https://doi.org/10.1111/j.1741-2358.1997.tb00642.x.
104. Lazarevic, V., et al. "Analysis of the Salivary Microbiome Using Culture-Independent Techniques." Journal of Clinical Bioinformatics, vol. 2, Dec. 2012, 1-8. https://doi.org/10.1186/2041-1480-2-1.
105. Qin, J., et al. "A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing." Nature, vol. 464, no. 7285, 4 Mar. 2010, pp. 59-65. https://doi.org/10.1038/nature08821.
106. Nicholson, J. K., et al. "Host-Gut Microbiota Metabolic Interactions." Science, vol. 336, no. 6086, 8 June 2012, pp. 1262-7. https://doi.org/10.1126/science.1223813.
107. Kump, P. K., et al. "Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does Not Induce Remission in Patients with Chronic Active Ulcerative Colitis." Inflammatory Bowel Diseases, vol. 19, no. 10, Sept. 2013, pp. 2155-65. https://doi.org/10.1097/MIB.0b013e31829b7804.
108. Amann, R., and B. M. Fuchs. "Single-Cell Identification in Microbial Communities by Improved Fluorescence In Situ Hybridization Techniques." Nature Reviews Microbiology, vol. 6, no. 5, May 2008, pp. 339-48. https://doi.org/10.1038/nrmicro1900.
109. Welker, M., and E. R. Moore. "Applications of Whole-Cell Matrix-Assisted Laser-Desorption/Ionization Time-of-Flight Mass Spectrometry in Systematic Microbiology." Systematic and Applied Microbiology, vol. 34, no. 1, Feb. 2011, pp. 2-11. https://doi.org/10.1016/j.syapm.2010.08.003.
110. Yanagisawa, N., et al. "Microfluidics-Based Bioassays and Imaging of Plant Cells." Plant and Cell Physiology, vol. 62, no. 8, Aug. 2021, pp. 1239-50. https://doi.org/10.1093/pcp/pcab075.
111. Duran-Pinedo, A. E., et al. "Community-Wide Transcriptome of the Oral Microbiome in Subjects with and without Periodontitis." The ISME Journal, vol. 8, no. 8, Aug. 2014, pp. 1659-72. https://doi.org/10.1038/ismej.2014.15.
112. Deo, P. N., and R. Deshmukh. "Oral Microbiome: Unveiling the Fundamentals." Journal of Oral and Maxillofacial Pathology, vol. 23, no. 1, Jan. 2019, pp. 122-8. https://doi.org/10.4103/jomfp.JOMFP_147_18.
113. Zaura, E., et al. "Acquiring and Maintaining a Normal Oral Microbiome: Current Perspective." Frontiers in Cellular and Infection Microbiology, vol. 4, 26 June 2014, 85. https://doi.org/10.3389/fcimb.2014.00085.
114. Na, H. S., et al. "Analysis of Oral Microbiome in Chronic Periodontitis with Alzheimer’s Disease: Pilot Study." [Publication details and DOI needed for citation].
115. Olsen, I. "The Oral Microbiome in Health and Disease." Oral Infections and General Health: From Molecule to Chairside, 2016, pp. 97-114. [DOI or publisher details needed for complete citation].